Cargando…
Adenosine 2 receptor regulates autophagy and apoptosis to alleviate ischemia reperfusion injury in type 2 diabetes via IRE-1 signaling
PURPOSE: This study aimed to determine the effect and mechanism of action of adenosine 2 receptor (A2R) activation on myocardial ischemia reperfusion injury (MIRI) under diabetic conditions. METHODS: MIRI type 2 diabetic rats and H9C2 cardiomyocytes were treated with A2R agonist and then subjected t...
Autores principales: | Yacouba Moukeila, Mohamed Bassirou, Thokerunga, Erick, He, Feng, Bongolo, Christian Cedric, Xia, Yun, Wang, Fuyu, Gado, Adamou Foumakoye, Mamoudou, Hama, Khan, Shahzad, Ousseina, Bonkano, Ousmane, Hadjara Abdoulkarim, Diarra, Drissa, Ke, Jianjuan, Zhang, Zongze, Wang, Yanlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039586/ https://www.ncbi.nlm.nih.gov/pubmed/36964482 http://dx.doi.org/10.1186/s12872-023-03116-y |
Ejemplares similares
-
Optimum cycles of induction chemotherapy in concurrent chemo-radiotherapy management of unresectable stage III non-small cell lung cancer: Results from a single institutional database
por: Yacouba, Mohamed Bassirou Moukeila, et al.
Publicado: (2023) -
Exosomes Derived from microRNA-27a-3p Overexpressing Mesenchymal Stem Cells Inhibit the Progression of Liver Cancer through Suppression of Golgi Membrane Protein 1
por: Bongolo, Christian Cedric, et al.
Publicado: (2022) -
Adenosine A2a Receptor Regulates Autophagy Flux and Apoptosis to Alleviate Ischemia-Reperfusion Injury via the cAMP/PKA Signaling Pathway
por: Xia, Yun, et al.
Publicado: (2022) -
The Value of Chinese Version GAD-7 and PHQ-9 to Screen Anxiety and Depression in Chinese Outpatients with Atypical Chest Pain
por: Lin, Qiuzhen, et al.
Publicado: (2021) -
Prevalence and Clinical Relevance of Schistosoma mansoni Co-Infection with Mycobacterium tuberculosis: A Systematic Literature Review
por: Baya, Bocar, et al.
Publicado: (2023)